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Management of Gastroesophageal Reflux
Disease:The Primary Care Strategy
Roger Jonesa
Guy's, King's and St Thomas'School ofMedicine, London, United Kingdom
Gastroesophageal reflux disease (GERD) is a common problem in the community and in general
practice. Generalpractitioners andfamilyphysicians need to understandpatients'reasonsfor con-
sultation and also be aware ofalarm symptoms suggestive ofserious disease. A primary care man-
agement strategyfor GERD isproposed, in which theplace ofendoscopic and other investigations
is defined, the role oflifestyle modification discussed, and recommendationsfor longer-term thera-
py and management are made.
INTRODUCTION
Most medical contacts take place in
general practice and primary care, and
most management decisions about gas-
troesophageal reflux disease (GERD) and
reflux-like dyspepsia are taken in the com-
munity and in primary care physicians'
offices. A primary care management strat-
egy for GERD needs to pay attention to
the epidemiological background, includ-
ing the frequency and distribution of
reflux-like symptoms in the community, to
the distinctive characteristics of patients
presenting in primary care for the first
time with reflux symptoms, to the need to
make timely, cost-effective diagnostic and
management decisions, avoiding unneces-
sary investigation and referral whenever
possible, and to the challenge ofproviding
long-term effective control of symptoms
and esophageal damage that is both
patient-centered and evidence-based.
REFLUX SYMPTOMS INTHE
COMMUNITY
Dyspeptic symptoms of all kinds are
very common in the general population. In
the United Kingdom the six-month preva-
lence of dyspepsia in the adult population
is in the region of40 percent [1], and com-
parable figures have been obtained from
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studies in North America, notably from
Talley's group at the Mayo Clinic [2]. The
most recent study, specifically measuring
the prevalence ofheartburn andreflux-like
symptoms in the community [3], confirms
apopulation prevalence in the region of40
percent.
There is considerable overlap,
demonstrated in the first two ofthese stud-
ies, between ulcer-like and reflux-like
symptoms, with 56 percent of the British
patients experiencing these symptoms on
the same or on different occasions.
Talley's group has also pointed out the
considerable symptomatic overlap
between upper and lower gastrointestinal
symptoms in the community. The preva-
lence of symptoms tends to fall with
increasing age, and symptom prevalence
is approximately equal in the sexes.
Self-care is the rule for the manage-
ment of dyspepsia and heartburn; only
about 25 percent of these patients ever
consult a general practitioner [1], so that
the majority ofpeople with upper abdom-
inal complaints take care of them without
entering formal medical care. Two studies
documenting the natural history of dys-
peptic symptoms suggest that non-con-
sulting patients tend to continue not to
consult over significant periods oftime [4,
5].
PRESENTATION IN PRIMARY
CARE
What are the factors that turn people
into patients? A detailed study of 66 con-
sulting and 69 non-consulting patients
with dyspepsia, identified from a commu-
nity survey, provide some evidence about
this [6]. There is certainly an increasing
tendency to consult with advancing age,
so that the majority of dyspeptic elderly
patients identified in the community will
have seen a doctor about their problems.
Consultation is approximately equal
between the sexes. Symptom frequency
and symptom severity are poor predictors
ofthe likelihood ofconsultation; there is a
weak effect related to the experience of
recent threatening ordisruptive life events,
but the main factors accounting for the
variance between consulting and non-con-
sulting have more to do with patients'
beliefs and concerns. Almost 75 percent of
patients consulting with dyspepsia are
worried that their symptoms may repre-
sent something serious orpotentially fatal,
up to 50 percent have concerns about can-
cer, either a general worry about having
cancer or a specific anxiety about gas-
trointestinal cancer, and approaching 75
percent, particularly those with reflux-like
symptoms, have concerns about heart dis-
ease.
This means that patients present in
primary care not only with diffusely-
formed symptom complexes, but also with
considerable and often inappropriate anxi-
eties about the significance oftheir symp-
toms. Many will have already tried over-
the-counter medication and may be
impelled to consult more by a desire to
obtain symptom relief than a need for
reassurance. A substantial number of
patients will, however, be harboring con-
cerns about potential serious causes of
their symptoms, and addressing these
clearly forms an important part of initial
management in primary care.
DIAGNOSIS AND EARLY
MANAGEMENT
The task of the generalist is to mar-
ginalize danger, while thatofthe specialist
is to marginalize uncertainty. In other
words, the first task of a general practi-
tioner or family physician, confronted
with a patient with ill-defined symptoms,
is to make a timely determination of
whether these symptoms represent a
potentially serious problem for which
urgent intervention is required. It is impor-
tant to remember that only a minority of
patients presenting in primary care will
have serious disease; while uppergastroin-
testinal problems account for 4 to 5 per-
cent of the work of a general practitionerJones: GERD in primary care 205
Table 1. Diagnosis and early management.
* Alarm symptoms are important; in the presence of alarm symptoms, including new
symptoms in patients aged over 45, investigation should be undertaken without delay.
* Predominant presenting symptoms need to be considered carefully, and the predomi-
nant symptom used to guide clinical diagnosis.
* Patients'concerns aboutthe meaning of symptoms and the impactof symptoms on their
quality of life may be just as important as the macroscopic severity of oesphagitis.
in the United Kingdom [7], new cases of
duodenal ulcer disease account for less
than 5 percent of patients with persistent
dyspeptic symptoms and a GP is likely to
see a new case of upper gastrointestinal
cancer only twice in every three years.
Accordingly, primary care physicians
need to adopta system oftriage, in orderto
separate the majority ofpatients with self-
limiting conditions which can be treated
without urgency, from the minority with
potentially serious disease. In order to do
this, a number oftactics are employed.
First, the concept of "alarm symp-
toms" is well accepted; patients with new
dyspeptic or reflux symptoms coming on
over the age of45 years, those with pain or
difficulty in swallowing, weightloss, early
satiety, evidence of anemia or other sys-
temic illness, should all be regarded as
having potentially serious diseases such as
esophageal stricture, ulcer, or cancer and
investigated, by referral or investigation as
appropriate, as swiftly as possible. Indeed,
the presence ofalarm symptoms mandates
speedy and definitive diagnosis.
Second, the predominant presenting
symptoms need to be considered carefully,
and consideration given to the possibility
of making an accurate clinical diagnosis.
This is problematic in upper gastrointesti-
nal conditions, and although the positive
and negative predictive values of reflux
symptoms for a final diagnosis of gastro
esophageal reflux disease are rather better
than those for duodenal ulcerdisease, they
are still relatively poor. For example, even
when heartburn and acid regurgitation
clearly dominate the patients' presenting
complaints, these symptoms possess high
specificity (89 percent and 95 percent
respectively), but much lower sensitivity
(38 percent and 6 percent) for a final diag-
nosis ofGERD. In one study, [8] one-third
of the patients reported such inconclusive
symptomatology at history taking that no
preliminary diagnosis about the presence
orabsence ofGERD couldbe made. In the
remaining patients a clinical diagnosis
based on a detailed history taken by an
experienced gastroenterologist had a sen-
sitivity of 78 percent and a specificity of
60 percent. Given the relatively low sensi-
tivity and specificity of endoscopy for a
definitive final diagnosis of GERD, this
raises considerable problems in making an
accurate clinical diagnosis.
There has been some optimism that
the administration of a short course of
effective doses of anti-secretory medica-
tion might offer an accurate diagnostic test
for the presence of GERD, or at least of
acid-related upper abdominal symptoms.
There is some evidence that this is a real-
istic objective. For example, Schindlbeck
and colleagues reported a study of an
"omeprazole test" in which omeprazole 40
mg twice daily was administered to
patients with symptoms suggestive of
GERD. When a 75 percent reduction in
symptom severity was defined as positive,
this test had a sensitivity of 83.3 percent
(compared with a much lower sensitivity
ofonly 27 percent when adosage of40 mg
daily was employed). They concluded that
the diagnosis of gastroesophageal reflux206 Jones: GERD in primary care
disease can, in practice, be ruled out if
symptoms do not improve with a limited
course of high-dose proton pump inhibi-
tion [9].
Third, the effect ofthe patients' symp-
toms, irrespective oftheir likely pathogen-
esis, needs to be considered. Ifpatients are
finding that their symptoms significantly
impair activities of daily living or if they
have anxieties about the possibilities of
serious disease, investigation may be
planned earlier. There is evidence from a
number of studies that consultation and
prescription rates fall following a negative
upper GI endoscopy in patients with upper
abdominal complaints, and the effect of
appropriate investigation should not be
underestimated. However, physicians also
have a responsibility to deal directly with
patients concerns; a sympathetically-taken
history, followed by an appropriate and
careful physical examination, may do
much to assure patients both that they are
being listened to and that their fears may
be ungrounded.
Early management in primary care is
currently controversial. There are two
linked problems; one is an over-emphasis
on pharmacological treatment for GERD
and the other continuing uncertainty about
the practicality and value of so-called
"lifestyle modification" as a therapeutic
modality. The literature relating to
lifestyle changes (weight loss, dietary
modifcation, smoking cessation, relax-
ation, exercise, etc.) is patchy and incon-
clusive. Although most reviews and guide-
lines relating to the management ofGERD
pay at least lip service to lifestyle modifi-
cation, the number of carefully-controlled
studies on the effects oflifestyle modifica-
tion and the likely feasibility of effecting
SYMPTOMATIC PATIENT
I
PREDOMINANTHEARTBURN/ ATYPICAL SYMPTOMS
REGURGlTATION ,/ I
I ALARM SYMPIOMS PPI test
Lifestyle advice
Resolve Lnefrtive Negative Positive
Empirical Rx EmpiricalRx
PPI 8weeks / PPIs 8 weeks
Resolve Ineffective/relapse Ineffecive/relapse Resolve
ENDOSCOPY
Oesophagitis Cancer/ Negative - Rx as
Barretts NUD
Maintenance/ Survey or pHmety /
ondemand surveillance \ negative
PPI
Maintenance/on
demand PPI
Figure 1. A primary care management strategy.Jones: GERD in primary care 207
modification in primary care is very few.
Dent [10] has emphasized that the relief
afforded by modem anti-secretory drugs is
seldom achieved by traditional non-drug
measures. There is evidence too that
physicians infrequently recommend
lifestyle modifications in GERD; a recent
survey from Virginia [11] reported that
less than half of a sample of patients with
GERD were given consistent and appro-
priate lifestyle advice. Older patients were
even less likely to receive appropriate
guidance, although lifestyle modifications
were more consistently suggested for
obese patients and heavy smokers. Given
the high costs of anti-secretory drugs and
of the endoscopic examination of patients
with upper abdominal complaints, more
research is clearly needed to determine the
most cost-effective way of making an
early and accurate diagnosis and to estab-
lish the precise place of lifestyle advice
and modification in the early management
ofpatients with GERD.
A PRIMARY CARE MANAGEMENT
STRATEGY
Despite these reservations and gaps in
evidence, it is possible to provide some
guidance on the management of GERD in
primary care, and a primary care manage-
ment strategy is outlined in the accompa-
nying figure (Figure 1).
Patients with predominant heartburn
and regurgitation, i.e., with typical symp-
toms and without alarm symptoms should
initially be managed by careful explana-
tion of the likely cause of their symptoms
and lifestyle advice where appropriate. If
this approach, together with over-the-
counter or prescription antacids, results in
symptom resolution, patients should be
encouraged to self-manage and self-med-
icate in the future.
If, however, lifestyle advice and sim-
ple measures are ineffective - and many
patients consulting family physicians will
already have tried some ofthese strategies
- empirical therapy (i.e., before evidence
has been obtained at endoscopy) with a
proton pump inhibitor (PPI) at standard
dosage for up to eight weeks can be
employed. If this results in resolution of
symptoms, there is no need for further
investigation at this stage, but if this
approach is ineffective or symptoms
relapse rapidly, endoscopy is indicated.
The endoscopic findings require careful
consideration. Microscopic esophagitis is
likely to require either on-demand or
maintenance therapy, generally with a PPI,
although in some patients a "step down"
apprQach to a less expensive form of ther-
apy may be feasible. Clearly patients with
cancer, or Barratt's esophagus need to be
referred for specialist management,
involving surgery and/or regular endo-
scopic surveillance.
Patients with typical GERD symp-
toms, but in whom endoscopy is negative,
represent aparticularproblem. As many as
40 percent of patients with significant
GERD will have normal endoscopies, and
so negative findings at initial endoscopy
do not exclude the diagnosis of GERD.
The role of pH monitoring, however,
remains controversial. There are issues of
access and cost for many primary care
physicians, and also ofinterpretation. It is
probably most appropriate to discuss indi-
vidual cases with an experienced gastroen-
terologist before embarking on further
investigations of this kind.
A further subgroup of patients with
typical GERD symptoms can emerge,
namely those with negative endoscopy and
negative pH-metry. These are best treated
as non-ulcer dyspepsia, using the range of
drugs currently employed for this condi-
tion, including prokinetic agents.
Patients with atypical symptoms and
without alarm symptoms can often be use-
fully investigated with a therapeutic trial
of anti-secretory drug, preferably a PPI.
Patients in whom aPPI testis negative, but
in whom GERD is still a likely diagnosis,
should be referred for endoscopy; those in
whom the PPI test is positive can reason-
ably be treated with empirical anti-secreto-
ry therapy with a PPI for up to eight208 Jones: GERD inprimary care
weeks, and will then follow the same algo-
rithmic pathway as patients in the "typi-
cal" category.
The role of Helicobacter pylori and
the place of Helicobacter eradication in
GERD remains controversial. It has been
suggested that patients infected with H.
pylori who take long-term PPIs are more
likely to develop accelerated gastric atro-
phy, making prophylactic eradication of
H. pylori in this group desirable.
However, an alternative view is that
because Helicobacter infection is so com-
mon, it is generally unlikely to lead to
harm, making eradication unnecessary.
Further information on this point is
required before a definitive recommenda-
tion can be made.
LONG-TERM MANAGEMENT
The overall aim ofthe long-term man-
agement ofpatients with GERD in prima-
ry care is to ensure that patients' symp-
toms are controlled as fully as possible,
and that their risk ofcomplications is min-
imized, and also that this is achieved in a
cost-effective way. In order to achieve
these goals, a number ofquestions remain
to be answeredbefore aprimary care strat-
egy for the long-term management of
GERD can be agreed upon:
1. The relative merits and disadvan-
tages of "step down" and "step up"
approaches to acid suppression. In other
words is it most appropriate to begin treat-
ment with high-dose anti-secretory thera-
py and to reduce the dose to the lowest
level compatible with suppression of
symptoms, oris itmore appropriate, as tra-
ditionally recommended, to begin with
simple anti-acid medication and to
increase the dose until control of symp-
toms is achieved? There is clinical and
computer modeling evidence that the for-
mer approach is more likely to be cost-
effective, although the findings of this
modeling exercise require confirmation in
a clinical trial [12, 13].
2. Should the long-term management
of GERD be exclusively symptom-led, or
does endoscopy have a role in manage-
ment? Given the mismatch between clini-
cal symptoms and the endoscopic find-
ings, it might be argued that the risk of
complications (stricture formation,
Barrett's esophagus, and cancer) could be
reduced if patients with unhealed erosive
lesions were identified and more appropri-
ately treated.
3..The role ofanti-reflux surgery, par-
ticularly techniques involving minimally
invasive approaches, needs to be clarified.
It is likely that many primary care physi-
cians regard anti-reflux surgery as aproce-
dure that should be reserved for those who
fail to respond to drug therapy. However,
there is accumulating evidence that anti-
reflux surgery represents a clinically
appropriate and cost-effective alternative
to long-term antiscretory therapy [14].
In conclusion, while it is possible to
sketch out a primary care strategy for the
management of GERD, a number of data
are still required to fill in the details. Well-
conducted diagnostic and clinical trials,
with robust health economics and health
services components, are required to
answer some of these outstanding ques-
tions
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